EPHA2 biallelic disruption causes syndromic complex microphthalmia with iris hypoplasia.
Aniridia
Cataract
EPHA2
Microphthalmia
PAX6
Journal
European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
06
04
2022
revised:
26
06
2022
accepted:
20
07
2022
pubmed:
3
8
2022
medline:
16
9
2022
entrez:
2
8
2022
Statut:
ppublish
Résumé
Disruption of any of the ocular development steps can result in ocular defects such as microphthalmia, coloboma and anterior segment dysgeneses including aniridia and cataract. All of these anomalies can be isolated or seen in association with each other. Except for aniridia (almost exclusively due to PAX6 mutations), most of these congenital ocular malformations are related to a wide genetic heterogeneity, as hundreds of genes are implied in ocular development. Here we describe a patient presenting with bilateral microphthalmia, congenital cataract, corneal dystrophy and iris hypoplasia, associated with extra-ocular features, who underwent an analysis of 119 ocular development related genes. Genetic testing revealed the presence of two truncating variants in the EPHA2 gene. While EPHA2 mutations are mainly known to be responsible for isolated dominant congenital cataract, we report here the first case of complex anterior segment dysgenesis caused by a biallelic EPHA2 mutation. This gene should be screened in case of aniridia with a negative PAX6 testing, as the ocular features of our patient clearly mimic those of PAX6 mutated patients. This observation enlarges the phenotype associated with EPHA2 variations and rise the insight of a possible PAX6-EPHA2 interaction that needs further investigations. Moreover, despite a great variability in ocular and extra-ocular phenotypes, mutations type and inheritance pattern, a possible genotype-phenotype correlation can also be drawn for this gene.
Identifiants
pubmed: 35918037
pii: S1769-7212(22)00155-0
doi: 10.1016/j.ejmg.2022.104574
pii:
doi:
Substances chimiques
Eye Proteins
0
Homeodomain Proteins
0
PAX6 Transcription Factor
0
Paired Box Transcription Factors
0
Repressor Proteins
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104574Informations de copyright
Copyright © 2022. Published by Elsevier Masson SAS.
Déclaration de conflit d'intérêts
Declaration of competing interest Authors declared no conflict of interest.